Mebicar

Mebicar (also known as Adaptol) is an anxiolytic medication produced by Latvian pharmaceutical company Olainfarm and has been notably sold in Russia and other countries. It is not approved for use by the Food and Drug Administration (FDA) in the U.S. or the European Medicines Agency (EMA) in the European Union.

Pharmacology

Mebicar has an effect on the structure of limbic-reticular activity, particularly on the hypothalamus emotional zone, as well as on all 4 basic neuromediator systems – GABAergic, cholinergic, serotoninergic, and adrenergic activity. It stabilizes the membranes of the brain cells and improves metabolism within the brain.

Medical Uses

Mebicar is used primarily as an anxiolytic. It is used for therapy of anxiety, fear, emotional tension or irritation, and insomnia. Mebicar has a mild tranquilizing effect and can be used to treat neuroses. It also has cardioprotective properties.

Side Effects

Mebicar is considered to be very safe with rare side effects. However, some patients may experience drowsiness, hypotension, or allergic reactions. It does not cause physical or psychological dependence.

Contraindications

Mebicar should not be used by individuals with severe liver or kidney dysfunction, pregnant women, or breastfeeding mothers. It should also not be used in conjunction with alcohol.

See Also

• Anxiolytic
• GABAergic
• Cholinergic
• Serotoninergic
• Adrenergic

‎